Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 49,33 | 83,49 | 2022-12-28 |
| Nordnet Pensionsförsäkring | 4,95 | 1,20 | 2022-12-28 |
| Avanza Pension | 4,69 | 1,21 | 2022-12-28 |
| Hans Nygren | 1,87 | 0,45 | 2022-12-28 |
| Rolf Karlsson | 1,82 | 0,44 | 2022-12-28 |
| Försäkringsaktiebolaget Skandia | 0,81 | 0,20 | 2022-12-28 |
| Olle Jönsson | 0,64 | 0,16 | 2022-12-28 |
| Creative Invest One AB | 0,36 | 0,09 | 2022-12-28 |
| Handelsbanken Liv Försäkring AB | 0,29 | 0,07 | 2022-12-28 |
| Hazina Ljungman | 0,27 | 0,21 | 2022-12-28 |
2023-05-26 Delårsrapport 2023-Q3
2023-08-28 Bokslutskommuniké 2023
2023-11-17 Delårsrapport 2024-Q1
2023-11-23 Årsstämma 2023